相关实验视频
Updated: May 16, 2025

07:38
Strategies for Assessing Autistic-Like Behaviors in Mice
Published on: September 20, 2024
745
在酸诱导的自闭症模型中,甲亚盐酸的治疗效果
Kubilay Doğan Kılıç1,2, Burak Çakar3, Yiğit Uyanıkgil4,5
1Department of Histology and Embryology, Faculty of Medicine, Ege University, İzmir, Türkiye. kubilay.dogan.kilic@ege.edu.tr.
Naunyn-Schmiedeberg's archives of pharmacology
|May 15, 2025
概括
石亚酸盐 (BSS) 在自闭症谱系障碍 (ASD) 的老鼠模型中有效降低了神经炎症和氧化应激. 这种治疗改善了行为缺陷,表明BSS.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 自闭症谱系障碍 研究研究
背景情况:
- 神经炎症和氧化应激,由巨细胞和微质细胞中的活性氧物种驱动,与自闭症谱系障碍 (ASD) 病理生理学有关.
- 这种破坏性循环涉及神经元功能障碍,细胞损失和行为障碍,由激活的微质释放的亲炎性介质加剧.
- 石亚盐酸 (BSS) 具有已知的抗炎和抗氧化特性,表明在神经退行性疾病中具有潜在的治疗价值.
研究的目的:
- 在酸 (PPA) 诱导的自闭症大鼠模型中,研究比斯木亚盐酸 (BSS) 在缓解神经炎症和氧化应激方面的疗效.
- 评估BSS治疗对与PPA诱导的自闭症类表型相关的行为异常的影响.
- 通过检查大脑组织中的生化和组织学标记来评估BSS的神经保护作用.
主要方法:
- 使用了30只雄性威斯塔尔白色老鼠,其自闭症类型的表型是由腹内注射酸 (PPA) 诱导的.
- 鼠被分为三个组:正常对照组,PPA+盐水组和PPA+BSS组,治疗时间为15天.
- 进行了行为测试 (社交,开放场地,被动回避) 和大脑组织的生化/组织学分析.
主要成果:
- 与对照组相比,PPA的使用显著增加了氧化应激和炎症标志物 (氨酸,TNF-α,IL-17).
- BSS治疗显著降低了这些炎症和氧化标志物,表明抑制了破坏性循环.
- 组织学分析显示,在接受BSS治疗的老鼠中,质细胞活化减少,神经元保存改善,以及社会互动,探索和记忆的显著改善.
结论:
- 在PPA诱导的自闭症模型中,石亚盐酸 (BSS) 通过减轻氧化应激和神经炎症,显示出显著的神经保护作用.
- 在这个模型中,BSS治疗改善了与社交互动,探索和记忆相关的行为缺陷.
- 这些发现表明,BSS具有治疗潜力,用于管理特征为神经炎症和氧化损伤的自闭症谱系障碍的各个方面.
相关概念视频
Autism Spectrum Disorder
45
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
45
Drugs for Treatment of Ulcerative Colitis in IBD
109
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
109

